ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1021

Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status

Romy Kallas1, Jessica Li2, Daniel Goldman3 and Michelle Petri3, 1Johns Hopkins Medical Institution, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Timonium, MD

Meeting: ACR Convergence 2020

Keywords: Comorbidity, Damage Index, risk assessment, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Multiple variables are known to contribute to development of organ damage in SLE patients, including prednisone use and ethnicity. The aim of this study was to evaluate the attributable risk due to comorbidities (hypertension, obesity, smoking), and socioeconomic factors on the total SLICC/ACR Damage Index (DI) and its sub-items in a large longitudinal prospective SLE cohort.

Methods: We analyzed data from a longitudinal cohort of 2,436 SLE patients who met the revised ACR or SLICC classification criteria (43% African-American, 57% Caucasian and 92% female). The SLICC/ACR DI was calculated based on organ damage that occurred after the diagnosis with SLE until the last visit. The outcome variable was the total damage score and that of each organ system at the last available cohort visit. We calculated the population attributable risk (PAR) for the total and each organ damage. Person month files since SLE diagnosis were created. At each month, variables were created to identify if patients had damage accrual. We analyzed the data using pooled logistic regression where the outcome was binary for each organ (accrual of damage). To account for the fact that some patients could contribute multiple damage events in the analysis, the GEE approach was used in fitting the model. Each model was adjusted for sex and age at the person month. Regression coefficients from the model were then used to calculate PAR.

Results: The mean total SLICC/ACR DI was 1.9 (SD=2.3). Hypertension was the strongest contributor to damage accrual, after adjusting for age and sex (Table 1 and 2). Hypertension was responsible for 30% of total damage: 70% of renal damage and 40% of cardiovascular damage was attributed to hypertension. The importance of hypertension was true regardless of ethnicity. Obesity was a strong contributor to neuro-psychiatric (23%) and renal (15.4) damage in Caucasians. It played a less important role in African-American patients, contributing only 3% and 0.8% to neuro-psychiatric and renal damage, respectively. Obesity was protective against skin damage in both African-Americans and Caucasians. Smoking contributed mostly to cardiovascular (13%) and skin (32%) damage. (Table 1). Only about 10% of any organ damage was accounted for by socioeconomic status. The 3 socioeconomic measures, education, low income, and insurance, contributed equally to total damage in patients with SLE. Socioeconomic status played a greater role in skin (28.3%) and peripheral vascular damage (21.5%), compared to damage in the other organ systems (Table 2).

Conclusion: Of the three comorbidities, hypertension had the highest PAR for total, renal and cardiovascular damage, regardless of ethnicity.  Obesity had a protective effect for skin damage.  The three measures of socioeconomic status were less important than hypertension.  Low income appeared to attribute more PAR than education or type of insurance.  The Eight Americas Study found that ethnicity, rather than socioeconomic status, explained the ethnic differences in mortality.  Our study suggests that ethnicity and hypertension are the most important contributors to organ damage (the strongest predictor of mortality).


Disclosure: R. Kallas, None; J. Li, None; D. Goldman, None; M. Petri, Astrazeneca, 2, 5, Exagen, 2, 5, GlaxoSmithKline (GSK), 2, 5, Eli Lilly and Company, 2, 5, AbbVie Inc., 5, Aleon Pharma International, Inc, 5, Amgen, 5, Annenberg Center for Health Sciences,, 5, Blackrock Pharma, 5, Bristol Myers Squibb, 5, Decision Resources, 5, Glenmark Pharmaceuticals, 5, INOVA, 5, IQVIA, 5, Janssen Pharmaceutical, 5, Merck EMD Serono, 5, Novartis, 5, Sanofi Japan, 5, Thermofisher, 5, UCB, 5.

To cite this abstract in AMA style:

Kallas R, Li J, Goldman D, Petri M. Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/organ-damage-in-systemic-lupus-erythematosus-is-attributable-more-to-comorbidity-hypertension-and-less-to-socioeconomic-status/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/organ-damage-in-systemic-lupus-erythematosus-is-attributable-more-to-comorbidity-hypertension-and-less-to-socioeconomic-status/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology